# Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy

> **NCT00153517** · PHASE2 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 126 (actual)

## Conditions studied

- Vaginosis, Bacterial
- Premature Birth
- Birth Weight
- Chorioamnionitis

## Interventions

- **DRUG:** oral versus vaginal metronidazole

## Key facts

- **NCT ID:** NCT00153517
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153517, "Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00153517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*